戈 鈺

研究成果

每年研究成果 2001 2009 2012 2014 2018 2019 2020 2021 2022 2023

• 76 文章
• 2 回顧型文獻
• 1 評論/辯論

每年研究成果

每年研究成果

搜尋結果

• 2023

  Health Utilities of Bilateral Severe-to-Profound Hearing Loss with Assistive Devices

  Chen, Y. W., Lin, P. H., Fang, T. Y., Wu, C. C., Wang, P. C., Wang, H. & Ko, Y., 6月 2023, 於: Healthcare (Switzerland). 11, 11, 1649.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Self-Help Devices 100%
  • Hearing Loss 71%
  • Visual Analog Scale 55%
  • utility value 43%
  • hearing impairment 39%

• Prescription patterns of granulocyte colony-stimulating factors in patients with breast cancer: A real-world study

  Hsu, S. W., Chiang, S. C., Hsu, J. C. & Ko, Y., 7月 2023, 於: PLoS ONE. 18, 7 July, e0288642.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Granulocyte Colony-Stimulating Factor 100%
  • Prescriptions 78%
  • Breast Neoplasms 59%
  • Febrile Neutropenia 41%
  • Drug Therapy 19%
• 2022

  An investigation of physicians' prescribing behaviors related to antidiabetic agents for Type 2 diabetes mellitus patients and associated factors in Taiwan

  Chen, X., Wang, C. Y. & Ko, Y., 2022, (接受/付印) 於: Current Medical Research and Opinion.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Taiwan 100%
  • Hypoglycemic Agents 96%
  • Type 2 Diabetes Mellitus 75%
  • Physicians 63%
  • Guidelines 21%

• Effectiveness and cost-effectiveness of trastuzumab emtansine in women with HER2-positive locally advanced or metastatic breast cancer: A systematic review and meta-Analysis

  Yeh, Y., Chen, C. & Ko, Y., 7月 1 2022, 於: Journal of Cancer Research and Therapeutics. 18, 4, p. 1061-1072 12 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Ado-Trastuzumab Emtansine 100%
  • Cost-Benefit Analysis 52%
  • Meta-Analysis 45%
  • Systematic Reviews 44%
  • Breast Neoplasms 38%
  1 引文 斯高帕斯（Scopus）

• Relationship between metformin use and lactic acidosis in advanced chronic kidney disease: The REMIND-TMU study

  Chen, C. C., Ko, Y., Chen, C. H., Hung, Y. J., Wei, T. E., Chang, T. H., Ke, S. S., Kuo, K. N. & Chen, C., 11月 2022, 於: American Journal of the Medical Sciences. 364, 5, p. 575-582 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Lactic Acidosis 100%
  • Metformin 83%
  • Chronic Renal Insufficiency 71%
  • Comorbidity 30%
  • Glomerular Filtration Rate 27%
  3 引文 斯高帕斯（Scopus）

• Talent cultivation in health technology assessment: an expert survey

  Wu, Y. S., Chen, C., Wang, L. C., Jian, L. S. & Ko, Y., 3月 8 2022, 於: BMC Medical Education. 22, 1, p. 157 157.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • expert survey 100%
  • technology assessment 84%
  • health 32%
  • expert 10%
  • Health Economics 6%
  2 引文 斯高帕斯（Scopus）
• 2021

  An evaluation of the healthcare costs associated with adverse events in patients with breast cancer

  Wang, L. C., Chen, H. M., Chen, J. H., Lin, Y. C. & Ko, Y., 9月 2021, 於: International Journal of Health Planning and Management. 36, 5, p. 1465-1475 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • adverse events 100%
  • cancer 67%
  • Health Care Costs 66%
  • Healthcare 57%
  • Breast Neoplasms 47%
  1 引文 斯高帕斯（Scopus）

• An evaluation of the healthcare costs of metastatic breast cancer: A retrospective matched cohort study

  Chen, H. M., Chen, J. H., Chiang, S. C., Lin, Y. C. & Ko, Y., 10月 29 2021, 於: Medicine. 100, 43, p. e27567

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Health Care Costs 100%
  • Cohort Studies 75%
  • Breast Neoplasms 71%
  • Costs and Cost Analysis 11%
  • Taiwan 9%
  2 引文 斯高帕斯（Scopus）

• Assessing knowledge and attitude of healthcare professionals on biosimilars: A national survey for pharmacists and physicians in taiwan

  Poon, S. Y. K., Hsu, J. C., Ko, Y. & Chiang, S. C., 11月 2021, 於: Healthcare (Switzerland). 9, 11, 1600.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Biosimilar Pharmaceuticals 100%
  • pharmacist 80%
  • Pharmacists 71%
  • Taiwan 71%
  • Healthcare 55%
  5 引文 斯高帕斯（Scopus）

• Cardiovascular outcomes and healthcare costs of liraglutide versus basal insulin for type 2 diabetes patients at high cardiovascular risk

  Huang, W. C., Chen, Y. C., Wu, C. H. & Ko, Y., 12月 2021, 於: Scientific Reports. 11, 1, 1430.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Liraglutide 100%
  • Health Care Costs 63%
  • Type 2 Diabetes Mellitus 53%
  • Insulin 48%
  • Cardiovascular Diseases 34%
  6 引文 斯高帕斯（Scopus）

• Effectiveness and healthcare costs of eribulin versus capecitabine among metastatic breast cancer patients in Taiwan

  Lin, Y. J., Kuo, C. N. & Ko, Y., 6月 2021, 於: Breast. 57, p. 18-24 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • eribulin 100%
  • Capecitabine 76%
  • Taiwan 60%
  • Health Care Costs 54%
  • Breast Neoplasms 38%

• Health utilities in patients with type 2 diabetes in Taiwan

  Chen, C. C., Chen, J. H., Chen, C. L., Lai, T. J. & Ko, Y., 12月 2021, 於: Healthcare (Switzerland). 9, 12, 1672.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • chronic illness 100%
  • Taiwan 99%
  • Diabetes Mellitus 80%
  • Type 2 Diabetes Mellitus 75%
  • Health 49%
  1 引文 斯高帕斯（Scopus）
• 2020

  A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan

  Diaby, V., Alqhtani, H., van Boemmel-Wegmann, S., Wang, C. Y., Ali, A. A., Balkrishnan, R., Ko, Y., Palacio, S. & de Lima Lopes, G., 2月 1 2020, 於: Breast. 49, p. 141-148 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Trastuzumab 100%
  • Taiwan 83%
  • Cost-Benefit Analysis 72%
  • Lapatinib 71%
  • Breast Neoplasms 53%
  8 引文 斯高帕斯（Scopus）

• An assessment of the psychometric properties of the Chinese version of the Gout Impact Scale

  Pao, C. H. & Ko, Y., 1月 2 2020, 於: Current Medical Research and Opinion. 36, 1, p. 17-21 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Gout 100%
  • Psychometrics 78%
  • Rheumatologists 5%
  • Pharmacists 4%
  • Taiwan 4%
  5 引文 斯高帕斯（Scopus）

• Conceptualization, development and psychometric evaluations of a new medication-related health literacy instrument: The chinese medication literacy measurement

  Lin, H. W., Chang, E. H., Ko, Y., Wang, C. Y., Wang, Y. S., Mafruhah, O. R., Wu, S. H., Chen, Y. C. & Huang, Y. M., 10月 1 2020, 於: International journal of environmental research and public health. 17, 19, p. 1-17 17 p., 6951.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • literacy 100%
  • Health Literacy 93%
  • Literacy 89%
  • Psychometrics 70%
  • Label 66%
  4 引文 斯高帕斯（Scopus）

• Costs and length of sepsis-related hospitalizations in Taiwan

  Chen, Y. J., Chen, F. L., Chen, J. H., Wu, M. T. M., Chien, D. S. & Ko, Y., 5月 29 2020, 於: Medicine. 99, 22, p. e20476

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Taiwan 100%
  • Sepsis 81%
  • Hospitalization 74%
  • Costs and Cost Analysis 62%
  • Fees and Charges 47%
  2 引文 斯高帕斯（Scopus）

• Cost-utility analysis of second-line anti-diabetic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin

  Chien, C. L., Chen, Y. C., Malone, D. C., Peng, Y. L. & Ko, Y., 9月 2020, 於: Current Medical Research and Opinion. 36, 10, p. 1619-1626 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Metformin 100%
  • Sodium-Glucose Transport Proteins 94%
  • Cost-Benefit Analysis 80%
  • Type 2 Diabetes Mellitus 69%
  • Quality-Adjusted Life Years 58%
  3 引文 斯高帕斯（Scopus）

• Dataset used in the economic evaluation trastuzumab-based regimens for HER-2 positive metastatic breast cancer patients in the Taiwanese healthcare setting

  Diaby, V., Wang, C. Y., Alqhtani, H., van Boemmel-Wegmann, S., Ali, A. A., Balkrishnan, R., Ko, Y., Palacio, S. & de Lima Lopes, G., 4月 2020, 於: Data in Brief. 29, 105194.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Trastuzumab 100%
  • Drug-Related Side Effects and Adverse Reactions 77%
  • Cost-Benefit Analysis 72%
  • Datasets 66%
  • Tomography 57%
  1 引文 斯高帕斯（Scopus）

• Health state utilities for metastatic breast cancer in Taiwan

  Chou, T. C., Chiang, S. C. & Ko, Y., 6月 2020, 於: Breast. 51, p. 57-64 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Taiwan 100%
  • Breast Neoplasms 64%
  • Health 49%
  • Drug-Related Side Effects and Adverse Reactions 46%
  • Visual Analog Scale 46%
  7 引文 斯高帕斯（Scopus）

• The Misconceptions and Determinants of Diabetes Knowledge in Patients with Diabetes in Taiwan

  Chen, C. C., Chen, C. L. & Ko, Y., 2020, 於: Journal of Diabetes Research. 2020, 2953521.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Taiwan 100%
  • Dialysis 34%
  • Blood Glucose 33%
  • Income 33%
  • Vegetarians 28%
  5 引文 斯高帕斯（Scopus）
• 2019

  An investigation of the determinants for community pharmacists' positive image and the needs for community pharmacists' services in Taiwan

  Tseng, K. H., Chang, E. H. & Ko, Y., 10月 1 2019, 於: International Journal of Health Planning and Management. 34, 4, p. 1354-1363 10 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Social Welfare 100%
  • pharmacist 93%
  • Pharmacists 82%
  • Taiwan 82%
  • determinants 59%
  1 引文 斯高帕斯（Scopus）

• Costs and Length of Stay of Hospitalizations due to Diabetes-Related Complications

  Cheng, S. W., Wang, C. Y. & Ko, Y., 1月 1 2019, 於: Journal of Diabetes Research. 2019, 2363292.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Diabetes Complications 100%
  • Diabetes Mellitus 78%
  • Length of Stay 75%
  • Hospitalization 73%
  • Costs and Cost Analysis 61%
  25 引文 斯高帕斯（Scopus）

• Epidemiology of sepsis in Taiwan

  Chen, Y. J., Chen, F. L., Chen, J. H., Wu, M. T. M., Chen, Y. L., Chien, D. S. & Ko, Y., 5月 1 2019, 於: Medicine. 98, 20, p. e15725 e15725.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Taiwan 100%
  • Sepsis 81%
  • Epidemiology 79%
  • Respiratory System 27%
  • Mortality 21%
  13 引文 斯高帕斯（Scopus）

• Patient preferences for diabetes-related complications in Taiwan

  Lin, Y. J., Wang, C. Y., Cheng, S. W. & Ko, Y., 1月 2 2019, 於: Current Medical Research and Opinion. 35, 1, p. 1-7 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Patient Preference 100%
  • Diabetes Complications 91%
  • Taiwan 89%
  • Diabetes Mellitus 71%
  • Visual Analog Scale 41%
  4 引文 斯高帕斯（Scopus）

• Prescribing patterns and healthcare costs of gout

  Lee, Y. Y., Kuo, L. N., Chen, J. H., Lin, Y. C., Chen, L. F. & Ko, Y., 6月 3 2019, 於: Current Medical Research and Opinion. 35, 6, p. 1051-1058 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Gout 100%
  • Health Care Costs 75%
  • Colchicine 14%
  • Non-Steroidal Anti-Inflammatory Agents 13%
  • Costs and Cost Analysis 8%
  2 引文 斯高帕斯（Scopus）
• 2018

  Cost-effectiveness of multidisciplinary collaborative care versus usual care in the management of high-risk patients with diabetes in Singapore: Short-term results from a randomized controlled trial

  Siaw, M. Y. L., Malone, D. C., Ko, Y. & Lee, J. Y. C., 12月 2018, 於: Journal of Clinical Pharmacy and Therapeutics. 43, 6, p. 775-783 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Singapore 100%
  • Risk Management 94%
  • Cost-Benefit Analysis 74%
  • Randomized Controlled Trials 58%
  • Costs and Cost Analysis 46%
  13 引文 斯高帕斯（Scopus）

• Evaluation of healthcare costs and utilization for patients with gout: a population-based matched cohort study

  Lee, Y-Y., Tang, C-H., Chen, J-H., Kuo, L-N. & Ko, Y., 4月 3 2018, 於: Current Medical Research and Opinion. 34, 4, p. 735-740 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Gout 100%
  • Health Care Costs 75%
  • Cohort Studies 57%
  • Population 32%
  • Costs and Cost Analysis 18%
  5 引文 斯高帕斯（Scopus）

• Health Care Costs and Utilization of Dabigatran Compared With Warfarin for Secondary Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation: A Retrospective Population Study

  Chi, N. F., Wang, Y., Chien, L. N., Chien, S. C. & Ko, Y., 2018, 於: Medical Care. 56, 5, p. 410-415 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Dabigatran 100%
  • Patient Acceptance of Health Care 89%
  • stroke 87%
  • Warfarin 79%
  • Secondary Prevention 73%
  2 引文 斯高帕斯（Scopus）

• Healthcare costs and utilization of diabetes-related complications in Taiwan: A claims database analysis

  Cheng, S-W., Wang, C-Y., Chen, J-H. & Ko, Y., 8月 2018, 於: Medicine. 97, 31, p. e11602

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Insurance Claim Review 100%
  • Diabetes Complications 70%
  • Taiwan 69%
  • Health Care Costs 62%
  • Diabetes Mellitus 55%
  27 引文 斯高帕斯（Scopus）

• Translation, revision, and validation of the chinese version of the satisfaction with oral anti-diabetic agent scale (C-SOADAS) in patients with type 2 diabetes mellitus

  Lin, Y. J., Wang, C. Y., Chang, E. H., Cheng, S. W. & Ko, Y., 5月 1 2018, 於: Patient Preference and Adherence. 12, p. 667-672 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • chronic illness 100%
  • Type 2 Diabetes Mellitus 75%
  • Hypoglycemic Agents 41%
  • drug 34%
  • Taiwan 28%
  3 引文 斯高帕斯（Scopus）
• 2017

  Cost of Osteoporotic Fractures in Singapore

  Ng, C. S., Lau, T. C. & Ko, Y., 5月 1 2017, 於: Value in Health Regional Issues. 12, p. 27-35 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Osteoporotic Fractures 100%
  • Singapore 97%
  • Indirect Costs 61%
  • Outpatient 56%
  • Costs and Cost Analysis 52%
  6 引文 斯高帕斯（Scopus）

• Development and validation of a Chinese medication literacy measure

  Yeh, Y. C., Lin, H. W., Chang, E. H., Huang, Y. M., Chen, Y. C., Wang, C. Y., Liu, J. W. & Ko, Y., 2017, 於: Health Expectations. 20, 6, p. 1296-1301 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Literacy 100%
  • medication 71%
  • literacy 57%
  • drug 13%
  • Nonprescription Drugs 11%
  18 引文 斯高帕斯（Scopus）

• Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): A randomized controlled trial

  Siaw, M. Y. L., Ko, Y., Malone, D. C., Tsou, K. Y. K., Lew, Y. J., Foo, D., Tan, E., Chan, S. C., Chia, A., Sinaram, S. S., Goh, K. C. & Lee, J. Y. C., 8月 2017, 於: Journal of Clinical Pharmacy and Therapeutics. 42, 4, p. 475-482 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Pharmacists 100%
  • Type 2 Diabetes Mellitus 75%
  • Randomized Controlled Trials 68%
  • Costs and Cost Analysis 62%
  • Physicians 19%
  58 引文 斯高帕斯（Scopus）
• 2016

  Economic evaluations of pharmacist-managed services in people with diabetes mellitus: A systematic review

  Wang, Y., Yeo, Q. Q. & Ko, Y., 4月 1 2016, 於: Diabetic Medicine. 33, 4, p. 421-427 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Pharmacists 100%
  • Cost-Benefit Analysis 87%
  • Diabetes Mellitus 80%
  • Systematic Reviews 74%
  • Economics 44%
  50 引文 斯高帕斯（Scopus）
• 2015

  Direct medical cost of stroke in Singapore

  Ng, C. S., Toh, M. P. H. S., Ng, J. & Ko, Y., 10月 1 2015, 於: International Journal of Stroke. 10, A100, p. 75-82 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Singapore 100%
  • Stroke 59%
  • Costs and Cost Analysis 53%
  • Delivery of Health Care 17%
  • Subarachnoid Hemorrhage 15%
  22 引文 斯高帕斯（Scopus）

• Direct medical cost of type 2 diabetes in Singapore

  Ng, C. S., Toh, M. P. H. S., Ko, Y. & Lee, J. Y. C., 3月 27 2015, 於: PLoS One. 10, 3, e0122795.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • noninsulin-dependent diabetes mellitus 99%
  • Singapore 95%
  • Insulin Derivative 79%
  • Type 2 Diabetes Mellitus 58%
  • health services 49%
  23 引文 斯高帕斯（Scopus）

• Patient-reported health preferences of anticoagulant-related outcomes

  Wang, Y., Xie, F., Kong, M. C., Lee, L. H., Ng, H. J. & Ko, Y., 10月 24 2015, 於: Journal of Thrombosis and Thrombolysis. 40, 3, p. 268-273 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Anticoagulants 100%
  • Warfarin 57%
  • Health 52%
  • Visual Analog Scale 49%
  • Stroke 49%
  11 引文 斯高帕斯（Scopus）
• 2014

  Assessment of preference for hormonal treatment-related health states among patients with breast cancer

  Tan, X. Y., Aung, M. M., Ngai, M. I., Xie, F. & Ko, Y., 5月 2014, 於: Value in Health Regional Issues. 3, 1, p. 27-32 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Health State 100%
  • cancer 66%
  • Breast Neoplasms 46%
  • Health 35%
  • health 33%
  8 引文 斯高帕斯（Scopus）

• Characteristics of unplanned hospital admissions due to drug-related problems in cancer patients

  Chan, A., Soh, D., Ko, Y., Huang, Y. C. & Chiang, J., 7月 2014, 於: Supportive Care in Cancer. 22, 7, p. 1875-1881 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Pharmaceutical Preparations 100%
  • Neoplasms 77%
  • Causality 37%
  • Drug-Related Side Effects and Adverse Reactions 37%
  • Hospitalization 29%
  27 引文 斯高帕斯（Scopus）

• Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation

  Wang, Y., Xie, F., Kong, M. C., Lee, L. H., Ng, H. J. & Ko, Y., 12月 9 2014, 於: Cardiovascular Drugs and Therapy. 28, 6, p. 575-585 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Dabigatran 100%
  • Rivaroxaban 99%
  • Warfarin 79%
  • Atrial Fibrillation 67%
  • Cost-Benefit Analysis 65%
  21 引文 斯高帕斯（Scopus）

• Costs and length of stay of drug-related hospital admissions in cancer patients

  Ko, Y., Gwee, Y. S., Huang, Y. C., Chiang, J. & Chan, A., 4月 1 2014, 於: Clinical Therapeutics. 36, 4, p. 588-592 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Length of Stay 100%
  • Singapore 84%
  • Costs and Cost Analysis 81%
  • Pharmaceutical Preparations 54%
  • Drug Costs 53%
  11 引文 斯高帕斯（Scopus）

• Knowledge, satisfaction, and concerns regarding warfarin therapy and their association with warfarin adherence and anticoagulation control

  Wang, Y., Kong, M. C., Lee, L. H., Ng, H. J. & Ko, Y., 2014, 於: Thrombosis Research. 133, 4, p. 550-554 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Warfarin 100%
  • International Normalized Ratio 31%
  • Patient Satisfaction 18%
  • Therapeutics 15%
  • Drug Interactions 13%
  74 引文 斯高帕斯（Scopus）
• 2013

  Comparison of the responsiveness of the SF-36, the Oxford Knee Score, and the Knee Society Clinical Rating System in patients undergoing total knee replacement

  Ko, Y., Lo, N. N., Yeo, S. J., Yang, K. Y., Yeo, W., Chong, H. C. & Thumboo, J., 11月 2013, 於: Quality of Life Research. 22, 9, p. 2455-2459 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Knee Replacement Arthroplasties 100%
  • Knee 78%
  • rating 72%
  • pain 17%
  • health status 8%
  30 引文 斯高帕斯（Scopus）

• Comparison of three medication adherence measures in patients taking warfarin

  Wang, Y., Kong, M. C. & Ko, Y., 11月 2013, 於: Journal of Thrombosis and Thrombolysis. 36, 4, p. 416-421 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Medication Adherence 100%
  • Warfarin 95%
  • International Normalized Ratio 41%
  • Visual Analog Scale 16%
  • Health Personnel 7%
  25 引文 斯高帕斯（Scopus）

• Health literacy and its association with disease knowledge and control in patients with hypertension in Singapore

  Ko, Y., Balasubramanian, T. D., Wong, L., Tan, M. L., Lee, E., Tang, W. E., Chan, S. C., Tan, A. S. L. & Toh, M. P. H. S., 10月 9 2013, 於: International Journal of Cardiology. 168, 4, p. e116-e117

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  12 引文 斯高帕斯（Scopus）
• 2012

  Clinical Impact of Drug-Drug Interaction Between Aspirin and Prednisolone at a Cancer Center

  Koomanan, N., Ko, Y., Yong, W. P., Ng, R., Wong, Y. P., Lim, S. W., Salim, A. & Chan, A., 2012, 於: Clinical Therapeutics. 34, 12, p. 2259-2267 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Prednisolone 100%
  • Drug Interactions 95%
  • Aspirin 90%
  • Pharmaceutical Preparations 40%
  • Drug-Related Side Effects and Adverse Reactions 38%
  1 引文 斯高帕斯（Scopus）

• Development and validation of a general health literacy test in Singapore

  Ko, Y., Lee, J. Y. C., Toh, M. P. H. S., Tang, W. E. & Tan, A. S. L., 3月 2012, 於: Health Promotion International. 27, 1, p. 45-51 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Health Literacy 100%
  • Singapore 93%
  • literacy 55%
  • health 36%
  • Vital Signs 15%
  20 引文 斯高帕斯（Scopus）

• Economic Evaluation of Anastrozole Versus Tamoxifen for Early Stage Breast Cancer in Singapore

  Shih, V., Chan, A., Xie, F. & Ko, Y., 5月 2012, 於: Value in Health Regional Issues. 1, 1, p. 46-53 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Anastrozole 100%
  • Singapore 79%
  • life years 76%
  • Economic Evaluation 74%
  • Quality-adjusted Life Years 70%
  7 引文 斯高帕斯（Scopus）

• Health and economic burden of hpv-related diseases in singapore

  Low, J. J. H., Ko, Y., Ilancheran, A., Zhang, X. H., Singhal, P. K. & Tay, S. K., 2012, 於: Asian Pacific Journal of Cancer Prevention. 13, 1, p. 305-308 4 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Singapore 100%
  • incidence 73%
  • cancer 67%
  • Economics 67%
  • Uterine Cervical Neoplasms 56%
  22 引文 斯高帕斯（Scopus）

• Health-related quality of life and glycaemic control in patients with Type 2 diabetes mellitus in Singapore

  Shim, Y. T., Lee, J., Toh, M. P. H. S., Tang, W. E. & Ko, Y., 8月 2012, 於: Diabetic Medicine. 29, 8, p. e241-e248

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Singapore 100%
  • Type 2 Diabetes Mellitus 65%
  • Quality of Life 55%
  • Primary Health Care 13%
  • Insulin 11%
  73 引文 斯高帕斯（Scopus）